New search | Conferencedetail
mail
Print view
 
 

2nd Next Generation Kinase Inhibitors Summit

Evvnt Promotion / evvnt
-
22.02.2023 - 23.02.2023  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 8:00 am to 6:00 pm
 
Conference themes
With strong effectiveness profiles and 20 years of FDA approval, kinase inhibitors have revolutionized oncology treatment. The success of current kinase inhibitor classes is nevertheless constrained by rising resistance and security concerns.
Scientific Society
Hanson Wade
Notes
Speakers: Erik Schaefer, Co-Founder, President, Chief Executive Officer and Chief Scientific Officer, AssayQuant Technologies Inc., Gerhard Mueller, Chief Scientific Officer, Anavo Therapeutics, Harish Dave, Chief Medical Officer, AUM Biosciences
 

Enquiries and Registration:

https://go.evvnt.com/1446853-3?pid=4832
Mr. Min Ratcliffe
 
Categories
Health Services, Public Health
Languages
English
Congress fees
Free: USD 0.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)newTreeÄrztekammer für WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzCharité International AcademyAlumni Club Medizinische Universität WienCenter of Excellence